MedTrace Logo

Effect of Vitamin D Supplementation on Hemoglobin A1c

NCT01354262 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-04-23

No results posted yet for this study

Summary

This is a prospective, randomized, non-blinded interventional study that will investigate the effect of a vitamin D supplement on HbA1c in patients with uncontrolled type 2 diabetes mellitus (DM) and vitamin D deficiency. The goal is to investigate whether correcting vitamin D deficiency will alter the HbA1c level in patients with type 2 DM and lower than normal vitamin D level. My hypothesis is that correcting vitamin D deficiency decreases HbA1c levels in patients with type 2 DM and vitamin D deficiency.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D

600 IU daily oral supplementation

DIETARY_SUPPLEMENT

Vitamin D

50,000 IU supplementation bi-monthly

Sponsors & Collaborators

  • Ascension Health

    lead INDUSTRY

Principal Investigators

  • Prabhat K Pokhrel, MD · Ascension Health

  • Kimberly R Barber, PhD · Ascension Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
34 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-01-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354262 on ClinicalTrials.gov